Clinical trial
Cerebrolysin in Patients Diagnosed With SAH - an Observational Cohort Study (PILOT)
NCT06429943 is registered in ClinicalTrials.gov with Pomeranian Medical University Szczecin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cerebrolysin in Patients Diagnosed With SAH - an Observational Cohort Study (PILOT)
- Lead sponsor
- Pomeranian Medical University Szczecin
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 15, 2021
- Completion date
- January 10, 2023
- Enrollment
- 47 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sah (subarachnoid hemorrhage)